{"title":"Association of Diabetes Management Self-efficacy with Adherence to Medication, Glycemic Control, and Disease Outcomes Among Type 2 Diabetes Patients","authors":"Ali Khalooei, Zohreh Hasheminejad","doi":"10.5812/semj-138227","DOIUrl":null,"url":null,"abstract":"Background: Diabetes management self-efficacy (DMSE) positively affects diabetes self-care behaviors and can lead to better glycemic control and improved disease outcomes in diabetes patients. Objectives: This study aimed to evaluate DMSE level and its relationship with medication adherence, glycemic control, and diabetes complications among type 2 diabetes (T2D) patients. Methods: A cross-sectional study was carried out from November 2019 to January 2020 on T2D patients who attended the Diabetes Center of the Kerman University of Medical Sciences. Data were collected using two validated questionnaires including the diabetes management self-efficacy scale (DMSES) to evaluate DMSE level and the eight-item Morisky medication adherence scale (MMAS) to assess adherence to medication. The SPSS statistical software version 22 was employed for data analysis. Results: Of 440 T2D patients entering the study, 72% were female with a mean (SD) age of 59.60 (10.48). The mean (SD) DMSE score of the respondents was 5.76 (1.87). A significant negative correlation was observed between DMSE with HbA1c (r = -0.289, P < 0.0001) and also with FBS (r = -0.229, P < 0.0001), but there was a significant positive correlation between DMSE and adherence to medication (r = 0.208, P < 0.0001). FBS level (β = -0.252, P < 0.0001), number of visits by specialty or subspecialty physicians (β = -0.139, P = 0.002), medication adherence score (β = 0.165, P < 0.0001), neuropathy (β = 0.142, P = 0.002), marital status β = 0.125, P = 0.004), household income (β = -0.126, P = 0.004), and blood glucose checks at home (β = 0.109, P = 0.013) were considered predictors of DMSE score. Conclusions: Diabetes management self-efficacy is considered suboptimal among T2D patients. Patients with higher DMSE have better adherence to medication, better blood glucose control, lower risk of neuropathy, and fewer visits by specialty and subspecialty physicians.","PeriodicalId":39157,"journal":{"name":"Shiraz E Medical Journal","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shiraz E Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/semj-138227","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Diabetes management self-efficacy (DMSE) positively affects diabetes self-care behaviors and can lead to better glycemic control and improved disease outcomes in diabetes patients. Objectives: This study aimed to evaluate DMSE level and its relationship with medication adherence, glycemic control, and diabetes complications among type 2 diabetes (T2D) patients. Methods: A cross-sectional study was carried out from November 2019 to January 2020 on T2D patients who attended the Diabetes Center of the Kerman University of Medical Sciences. Data were collected using two validated questionnaires including the diabetes management self-efficacy scale (DMSES) to evaluate DMSE level and the eight-item Morisky medication adherence scale (MMAS) to assess adherence to medication. The SPSS statistical software version 22 was employed for data analysis. Results: Of 440 T2D patients entering the study, 72% were female with a mean (SD) age of 59.60 (10.48). The mean (SD) DMSE score of the respondents was 5.76 (1.87). A significant negative correlation was observed between DMSE with HbA1c (r = -0.289, P < 0.0001) and also with FBS (r = -0.229, P < 0.0001), but there was a significant positive correlation between DMSE and adherence to medication (r = 0.208, P < 0.0001). FBS level (β = -0.252, P < 0.0001), number of visits by specialty or subspecialty physicians (β = -0.139, P = 0.002), medication adherence score (β = 0.165, P < 0.0001), neuropathy (β = 0.142, P = 0.002), marital status β = 0.125, P = 0.004), household income (β = -0.126, P = 0.004), and blood glucose checks at home (β = 0.109, P = 0.013) were considered predictors of DMSE score. Conclusions: Diabetes management self-efficacy is considered suboptimal among T2D patients. Patients with higher DMSE have better adherence to medication, better blood glucose control, lower risk of neuropathy, and fewer visits by specialty and subspecialty physicians.
背景:糖尿病管理自我效能感(DMSE)对糖尿病患者的自我护理行为有积极影响,可导致糖尿病患者更好的血糖控制和改善疾病结局。目的:本研究旨在评估2型糖尿病(T2D)患者DMSE水平及其与药物依从性、血糖控制和糖尿病并发症的关系。方法:对2019年11月至2020年1月在克尔曼医学科学大学糖尿病中心就诊的T2D患者进行横断面研究。采用糖尿病管理自我效能量表(DMSES)评估DMSE水平,采用Morisky药物依从性量表(MMAS)评估药物依从性。采用SPSS统计软件22进行数据分析。结果:进入研究的440例T2D患者中,72%为女性,平均(SD)年龄为59.60(10.48)岁。被调查者的DMSE平均分(SD)为5.76分(1.87分)。DMSE与HbA1c呈显著负相关(r = -0.289, P <0.0001)和FBS (r = -0.229, P <0.0001),但DMSE与药物依从性之间存在显著正相关(r = 0.208, P <0.0001)。FBS水平(β = -0.252, P <0.0001)、专科或亚专科医生就诊次数(β = -0.139, P = 0.002)、药物依从性评分(β = 0.165, P <0.0001)、神经病变(β = 0.142, P = 0.002)、婚姻状况(β = 0.125, P = 0.004)、家庭收入(β = -0.126, P = 0.004)和家庭血糖检查(β = 0.109, P = 0.013)被认为是DMSE评分的预测因素。结论:糖尿病管理自我效能在t2dm患者中被认为是次优的。DMSE较高的患者对药物的依从性较好,血糖控制较好,神经病变风险较低,专科和亚专科医生就诊次数较少。